The objective of this study was to use a nationwide epidemiological survey to investigate the factors that affect within-visit blood pressure (BP) variability. We analyzed the Korean National Health and Nutrition Examination Survey (KNHNES) data for 2005 (n ¼ 5488). We examined three within-visit BP variability parameters that include the following: the alarm reaction (AR), defined as the first BP reading minus the third BP reading; the BP discrepancy, defined as the maximal BP reading minus the minimal BP reading (DBPmax); and the s.d. (BPSD). Age, fasting glucose, eGFR, total cholesterol, LDL cholesterol, and the metabolic syndrome (MetS) score were the relevant factors that affected the systolic AR, DSBPmax and SBPSD. Multiple linear regression models revealed that age (Po0.0001), the office systolic BP (SBP) level (Po0.0001), the MetS score (Po0.0001), the female gender (P ¼ 0.007) and the eGFR (P ¼ 0.049) were independently associated with the systolic AR, whereas age (Po0.0001), the office SBP level (Po0.0001), and the female gender (P ¼ 0.024 and 0.022) were independently associated with DSBPmax and SBPSD, respectively. Within-visit BP variability, especially the variability associated with the SBP, was significantly associated with increased age, female gender and cardiovascular risk factors, such as hypertension, low eGFR and adverse glucose and lipid profiles. In addition, increased age, female gender, the eGFR and the MetS score were independently relevant factors that affected the systolic AR. Systolic within-visit BP variability and systolic AR are associated with cardiovascular risk factors.
INTRODUCTION
Casual blood pressure (BP) measurements based on multiple clinical readings are generally used to make clinical decisions and determine prognoses. [1] [2] [3] More recently, the concept that variability in BP measurements has a prognostic value associated with cardiovascular events has challenged the old mantra in hypertension management that 'only the casual clinic BP counts'. [4] [5] [6] [7] Studies of BP variability have generally used noninvasive 24-hour ambulatory BP monitoring to assess diurnal patterns of BP, BP variability and their relationship to target organ damage and cardiovascular events. These studies have demonstrated a strong association between longer-term variability in systolic BP (SBP) and the risk of stroke and coronary artery disease, independent of absolute BP values. 6, [8] [9] [10] [11] Data on visit-to-visit and within-visit BP variability have been obtained primarily through secondary analyses of randomized controlled trials that included selected populations, such as highrisk patients. Data on the correlates or associated risk factors with within-visit variability of BP in the general population are limited. On the basis of the data from a nationwide survey, this study aimed to evaluate the relevant factors that affect within-visit BP variability.
PATIENTS AND METHODS Participants
We analyzed data for 2005 obtained from the Korea National Health and Nutrition Examination Survey (KNHANES), a cross-sectional, nationally representative survey with a stratified multistage sampling design. For the analysis, we selected participants who had three BP readings during one clinic visit, and we documented their baseline characteristics (smoking status, body mass index (BMI), laboratory data). As shown in Figure 1 , a total of 5488 adults (X19 years) were included in the analysis.
The participants were divided into the following four age groups: 1475 participants aged 19-35 years, 1905 participants aged 36-50 years, 1219 participants aged 51-64 years and 889 participants aged X65 years.
The participants were also divided into hypertensive (EH) and normotensive (NT) groups, according to their BP measurements and their histories of receiving antihypertensive medication. Participants with a BP of X140/90 mm Hg or who had received antihypertensive medication were included in the EH group. Of the 1365 hypertensive subjects, 680 were on antihypertensive therapy (drug subgroup), and 685 were not (no-drug subgroup). The smoker's group was defined as current smokers.
Blood pressure measurement
In the survey, auscultatory BP measurements were used. The participants were asked to rest for at least 5 min before the BP measurement. A trained nurse took three BP measurements consecutively on either arm with the same calibrated mercurial sphygmomanometer. The second and third BP measurements were performed at least 60 s after the first. The average of the second and third measurements was defined as the office BP.
The within-visit BP discrepancy (DBPmax) was defined as the maximal BP minus the minimal BP obtained from the three measurements.
Definition of the metabolic syndrome score 
Statistical methods
All data are presented as mean±s.d.'s. The SPSS 18.0 statistical package (SPSS Company, Chicago, IL, USA) was used for the analysis of covariance and Student's paired t-test. For the hypertension prevalence, according to the three BP measurements, the statistical difference was testified by using generalized estimating equations with exchangeable correlation to adjust between-subject variability or clustering by a repeated analysis of variance (ANOVA). A correlation analysis was performed to assess which factors were related to the within-visit BP variability parameters. Spearman's correlations between within-visit BP variability parameters and gender and smoking status were also calculated separately. Spearman's correlations were used because the gender and smoking values were not normally distributed. Statistical significance was defined as a P-value o0.05. For a multiple linear regression analysis for within-visit BP variability parameters, we constructed a model using data associated with age, gender, the office BP, smoking, the eGFR and the MetS score. To analyze the effect of the use of antihypertensive medication, multiple regression analyses were also performed according to the antihypertensive medication status. In the multiple regression model, the MetS score was calculated using the MetS components; however, the criteria of an elevated arterial pressure was not used in the calculations to avoid a statistical doubling of the effects of BP in the multiple regression model that included office BP.
RESULTS
The characteristics of the participants The demographic and clinical characteristics of the study participants are presented in (Figure 2 ). The estimate of the prevalence of a BP of 140/90 mm Hg or higher on the basis of the first measurement (n ¼ 1235, 22.5%) differed from those on the basis of the second (n ¼ 1110, 20.3%) and third (n ¼ 1053, 19.2%) measurements, respectively (Po0.0001, generalized estimating equations).
Comparison of within-visit BP variability between genders The average SBP of the female participants was lower than that of the male participants, but their average systolic AR was higher. Similarly, the females had a lower average diastolic BP (DBP) and a higher diastolic AR than the male participants. However, DBPmax and BPSD were not significantly different between the genders. Our study showed that within-visit SBP variability parameters increased substantially in the female participants after adjusting for other covariates (age, BMI, fasting glucose, eGFR and lipid profile) (Figure 3 ).
Comparison of within-visit BP variability according to age All SBP variability parameters increased with age. When the data for the group aged 19-35 years were excluded, diastolic BP variability parameters also increased with age. After correcting for other covariates (gender, BMI, fasting glucose, eGFR and lipid profile), the within-visit BP variability parameters, especially the variability associated with the SBP, increased with age ( Figure 4 ).
Comparison of within-visit BP variability according to blood pressure or smoking status SBP and SBP variability were higher in the EH group than in the NT group. The systolic AR of the drug subgroup was higher than that of the no-drug subgroup. There were no differences in DSBPmax and SBPSD between the groups. These findings suggest that hypertensive subjects, especially those receiving antihypertensive medications, have a greater pressor effect on BP measurements.
In contrast, in the case of DBP, DDBPmax and DBPSD were higher in the EH group, whereas diastolic AR was comparable between the two groups. However, the diastolic ARs of the drug subgroup was again higher than those of the no-drug subgroup (Table 3) . Compared with nonsmokers, the systolic and diastolic BPs were higher in smokers, but AR1-3 was lower ( Table 3 ).
The correlation of relevant factors and within-visit BP variability We used correlation analysis to assess which factors were related to within-visit BP variability (Table 4) . Increased age, female gender and elevations in the first SBP measurement, fasting glucose, eGFR and the lipid profile were related to the AR in SBP. Increased age and elevations in the first SBP measurement, BMI, fasting glucose, eGFR and the lipid profile were related to DSBPmax and SBPSD. Similarly, increased age, female gender, and elevations in the first DBP, the BMI and the eGFR were related to the AR in DBP; and increased age and elevations in eGFR and the first DBP were related to DDBPmax and DBPSD. 
Multiple linear regression analyses for within-visit BP variability
The possible determinants for within-visit BP variability were assessed through a multiple linear regression analysis model (Table 5 ). For the systolic AR, age, the level of the office SBP, the female gender, the eGRF and the MetS score were the independent factors. In male subjects, age (b ¼ 0.043, Po0.0001) and the MetS score (b ¼ 0.24, P ¼ 0.02) were the independent factors for systolic AR. However, in the female subjects, age (b ¼ 0.044, Po0.0001), the level of the SBP (b ¼ -0.029, Po0.0001) and the MetS score (b ¼ 0.328, P ¼ 0.003) were the independent factors for systolic AR. Age, level of the office SBP level and female gender were independently associated with DSBPmax and SBPSD. No association was found between diastolic within-visit BP variability parameters and any cardiovascular risk factors.
Regarding the effect of antihypertensive medication on the multiple regression model, as shown in the middle and lower panels of Table 5 , the effect of gender and the eGFR was more strongly associated with AR1-3 in the drug subgroup, whereas the MetS score and the office BP was more obviously associated with AR1-3 in the no-drug subgroup. In contrast, regarding DSBPmax and SBPSD, the gender effect was blunted in the drug subgroup.
DISCUSSION
The epidemiological features of within-visit BP variability and the related factors were established for the first time in this study of the general population in a nationwide survey. We found that the AR within a visit was significantly associated with age, the first BP measurement and the female gender, as well as other risk factors, such as hypertension and elevated glucose and lipid profiles. Clearly, within-visit BP variability, especially the variability associated with the SBP, correlated with cardiovascular risk profiles. Moreover, the first BP measurement and its relationship to withinvisit BP variability may also have substantial clinical significance for cardiovascular prognoses. As shown in the multiple linear regression analysis, age and the MetS score were independently associated with the systolic AR. The office SBP level is negatively associated with the AR, which is the opposite of the findings from the first SBP measurements. These findings seem to be the result of how the AR is calculated.
Although BP estimates on the basis of readings at a first visit are likely to overestimate an individual's true BP, 14 our results suggest that BP estimates on the basis of repeated measurements within a single clinic visit in an epidemiological survey may be useful as long as the AR or within-visit BP variability are carefully considered.
The transient rise in BP during a clinic visit relative to out-ofoffice BP measurements is usually referred to as the white-coat effect (WCE). However, BP variability is also present during successive measurements in a clinic, which is an effect that is interpreted as a hemodynamic consequence of a patient's AR to the pressor effect of the clinic visit or of the measurement procedure itself. Figure 2 . Extent of the absolute difference between maximum and minimum systolic blood pressure (DSBPmax) and diastolic blood pressure (DDBPmax).
Within-visit BP variability among individuals undergoing BP measurements may be a component of and associated with WCE. 15 The variability may also be related to multiple factors, such as respiratory, neurological or emotional states (for example, anxiety). Pickering et al. 16 proposed that being in the clinic itself has a pressor effect on BP such that baseline measures (taken before the physician enters the room) are already elevated and the WCE is underestimated. A change in the emotional state and sympathetic activity over B5 min can increase BP variability and the measurement of BP variability can be used to evaluate the variation in emotional and sympathetic activity. 17 The increase in BP variability in hypertensive subjects may be partially explained by the diminished baroreflex function associated with the increased stiffness and decreased compliance of the large elastic arteries. 9 The diminished baroreflex function is related to an exaggerated pressor response in reaction to mental and physical stimuli. 18 The perception of being hypertensive is associated with greater anxiety during clinic BP measurements and increases the WCE independent of the true BP level. 19 In addition, our results suggest that the pressor effect on BP measurements in hypertensive subjects is greater in those receiving antihypertensive medications than untreated subjects. Abbreviations: AR, alarm reaction; BMI, body mass index; DBP, diastolic blood pressure; DiaAR1-3, diastolic alarm reaction defined as the first BP minus third BP; DBPSD, s.d. of measured diastolic blood pressures; DDBPmax, maximal diastolic BP minus minimal diastolic BP; eGFR, estimated glomerular filtration rate; MetS score, number of components of metabolic syndrome; Office SBP, the average of the second and third systolic blood pressure measurement; Office DBP, the average of the second and third diastolic blood pressure measurement; SBPSD, s.d. of measured systolic blood pressures; SysAR1-3, systolic alarm reaction defined as the first BP minus third BP; DSBPmax, maximal systolic BP minus minimum systolic BP; 1st SBP, first measure systolic blood pressure; 1st DBP, first measured diastolic blood pressure. Abbreviations: B, unstandardized regression coefficient; CI, confidence interval; MetS SysAR, systolic alarm reaction between the first and the third measurements; Office SBP, the average of the second and third blood pressure measurement; score, number of components of metabolic syndrome other than the criteria of raised arterial pressure; SBPSD, s.d. of measured systolic blood pressures; DSBPmax, the absolute difference between maximum and minimum systolic blood pressure.
The perception of being hypertensive is associated with increased anxiety during clinic BP measurements, and an increase in the WCE has been described in the literature. 19 The female gender was more closely associated with the AR. Previous studies have demonstrated a similar relationship. Myers et al. 20 reported that women were significantly more likely than men to experience the WCE after correcting for differences in age and office BP values. A similar relationship has been described by Su et al., 17 who confirmed that female participants were more likely to exhibit greater discrepancies in BP. There may be intrinsic factors that increased the variability in BP measurements in the female participants, such as the instability of the autonomic nervous system and the more obvious emotional changes during BP measurements. Considering that the results of the association between females and AR1-3 were mainly observed in the drug subgroup, there may be a gender difference in reference to emotional stabilization in the course of antihypertensive medication. In contrast, the gender effect for DSBPmax and SBPSD was not as significant in the drug subgroup. This finding suggests that the AR followed by a decrease in anxiety during the subsequent measurements is not a random variation and may be different from the other variables of withinvisit BP variability, such as DSBPmax and SBPSD.
We have shown that elderly patients have a significantly higher rate of within-visit BP variability. Su et al. 17 reported that aging itself is an important facilitating factor for increased levels of BP discrepancies among three BP readings. The WCE and baroreflex impairment associated with increased stiffness and decreased compliance of the arteries may also have a role. 9, 21 We also documented an association between the magnitudes of within-visit variability in SBP and fasting glucose, eGFR, total cholesterol and LDL cholesterol. In addition, MetS score and eGFR were independently associated with systolic AR. A previous study reported that BP variability in ambulatory BP monitoring readings was an independent predictor for cardiovascular mortality in the general population, and high BP variability was also associated with a prevalence of obesity and hyperlipidemia. 9 Recent data suggest that the evidence for within-visit BP variability as a risk factor for events is weaker than other components of BP variability, and diurnal and long-term visit-tovisit BP variability seems to be a more promising route of inquiry. 22 However, there is little reliable evidence concerning the association between within-visit BP variability and cardiovascular risk and prognosis.
It is well-known that the first BP reading with cuff-based measurements, even after resting, is the least reliable and should be discarded. 23 Moreover, the first-measured BP is generally thought to account for the AR or WCE, and is usually dismissed as an unreliable estimation of the casual BP. 4, 24, 25 However, we have shown that the first-measured BP is more prone to within-visit BP variability among successive BP measurements in a clinic visit, and within-visit BP variability may be significantly associated with cardiovascular risk profiles. Ohkubo et al. 26 have also reported that home-measured BP, including even the initial first home BP values (one measurement), were more significantly related to stroke risk than conventional BP values (mean of two measurements). 26 More research is needed to understand fully the clinical significance of the first-measured BP and the association between within-visit BP variability, especially in reference to the AR and cardiovascular risks, and large-scale pooled analyses of multiple cohorts will be required.
This study has several limitations that should be mentioned. First, as a retrospective and cross-sectional study, causal relationships could not be established. To confirm the association between within-visit BP variability and cardiovascular risk and prognosis, long-term prospective randomized controlled studies are needed. Second, because ambulatory BP monitoring and visitto-visit BP data for the participants were not available, we were not able to compare the within-visit BP variability to visit-to-visit BP variability or the s.d. of BP measurements over 24 hours. Finally, major life-style-related factors, such as drinking, exercise or dietary habits were not taken into account.
In conclusion, within-visit BP variability is significantly associated with increased age, the female gender and cardiovascular risk factors, such as hypertension, low eGFR, and adverse glucose and lipid profiles. In addition, increased age, the female gender, a low eGFR and the MetS score were independently relevant factors for systolic AR. Long-term outcome studies are needed to prove the clinical significance of within-visit blood pressure variability.
What is known about this topic BP variability across several visits may be an important risk factor for stroke, coronary heart disease and all-cause mortality. The diurnal variability of BP during a 24-hour period using ambulatory BP monitoring has been associated with the subsequent occurrence of cardiovascular disease events.
What this study adds Within-visit BP variability is significantly associated with increased age, female gender and cardiovascular risk factors, such as hypertension, a low eGFR, and adverse glucose and lipid profiles. In addition, increased age, female gender, eGFR and MetS scores were independently relevant factors for systolic AR.
